Given that FTO is a key obesity-associated gene and an important factor controlling feeding behavior and energy expenditure, it could be likely that metformin elicits direct actions on obesity via adiposity reduction. Here, FTO is linked to obesity due to melanocortin 4 receptor deficiency.